Smith Group Asset Management’s Myriad Genetics MYGN Stock Holding History

Smith Group Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,790	Closed	-$50K	–	422
2019 Q2	$50K	Hold	1,790	–	–	﹤0.01%	274
2019 Q1	$59K	Sell	1,790 -5,500	-75%	-$167K	﹤0.01%	292
2018 Q4	$212K	Sell	7,290 -200	-3%	-$7.2K	0.01%	239
2018 Q3	$345K	Buy	+7,490	New	+$333K	0.01%	213
2017 Q3	–	Sell	-14,290	Closed	-$369K	–	462
2017 Q2	$369K	Sell	14,290 -100	-0.7%	-$2.12K	0.01%	230
2017 Q1	$276K	Sell	14,390 -10	-0.1%	-$177	0.01%	233
2016 Q4	$240K	Sell	14,400 -100	-0.7%	-$1.81K	0.01%	236
2016 Q3	$298K	Hold	14,500	–	–	0.01%	218
2016 Q2	$444K	Sell	14,500 -400	-3%	-$13.9K	0.01%	185
2016 Q1	$558K	Sell	14,900 -160	-1%	-$6.03K	0.02%	168
2015 Q4	$650K	Buy	+15,060	New	+$636K	0.02%	192
2015 Q2	–	Sell	-328	Closed	-$12K	–	421
2015 Q1	$12K	Buy	328 +127	+63%	+$4.55K	﹤0.01%	379
2014 Q4	$6K	Hold	201	–	–	﹤0.01%	389
2014 Q3	$7K	Sell	201 -492,177	-100%	-$18.4M	﹤0.01%	356
2014 Q2	$19.2M	Buy	492,378 +492,200	+276,517%	+$18.3M	0.71%	64
2014 Q1	$6K	Sell	178 -758,861	-100%	-$23.5M	﹤0.01%	356
2013 Q4	$15.9M	Hold	759,039	–	–	0.6%	72
2013 Q3	$17.8M	Hold	759,039	–	–	0.74%	61
2013 Q2	$20.4M	Buy	+759,039	New	+$22M	0.88%	44

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Smith Group Asset Management's MYGN Position: Q3 2019 in Review

Smith Group Asset Management sold out of Myriad Genetics (MYGN) in Q3 2019, closing a stake of 1,790 shares — an estimated $50K sold.

Smith Group Asset Management first reported a position in MYGN in Q2 2013 and held it in 19 quarters. The position peaked at $20.4M in Q2 2013. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2019.

Smith Group Asset Management reported no remaining Myriad Genetics position as of Q3 2019 after selling out during the quarter.
Smith Group Asset Management sold 1,790 Myriad Genetics shares in Q3 2019, an estimated $50K.
Smith Group Asset Management first reported a position in Myriad Genetics in Q2 2013 and held it in 19 quarters.
Smith Group Asset Management's Myriad Genetics position peaked at $20.4M in Q2 2013.
221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2019.

Based on Smith Group Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.